Experience with Thymoglobulin® induction therapy in pancreas transplant recipients.

被引：0
|
作者：
Wiland, AM
Fink, JC
Philosophe, B
Farney, AC
Schweitzer, EJ
Colonna, JO
Weir, MR
Bartlett, ST
机构：
[1] Univ Maryland, Sch Med, Dept Pharm Serv, Baltimore, MD 21201 USA
[2] Univ Maryland, Sch Med, Div Nephrol, Baltimore, MD 21201 USA
[3] Univ Maryland, Sch Med, Dept Surg, Baltimore, MD 21201 USA
来源：
TRANSPLANTATION | 2000年 / 69卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
1136
引用
收藏
页码：S408 / S408
页数：1
相关论文
共 50 条
  • [31] THYMOGLOBULIN INDUCTION IN LIVING DONOR KIDNEY TRANSPLANT RECIPIENTS
    Oeztuerk, A.
    Klein, T.
    Jazra, M.
    Wunsch, A.
    Michalski, S.
    Viebahn, R.
    Schenker, P.
    TRANSPLANT INTERNATIONAL, 2010, 23 : 35 - 35
  • [32] Thymoglobulin in the treatment of acute cellular rejection in pediatric kidney transplant recipients.
    Goldberg, Aviva
    Langman, Craig
    Zielinski, Tresa
    Kunzon, Deborah
    Cohn, Richard
    PEDIATRIC TRANSPLANTATION, 2007, 11 : 88 - 89
  • [33] T regulatory cells after induction therapy with Campath-1H, vs Thymoglobulin vs Daclizumab in kidney transplant recipients.
    Carreno, MR
    Cirocco, R
    Mathew, J
    Ciancio, G
    Burke, GW
    Miller, J
    Esquenazi, V
    AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 : 570 - 570
  • [34] FK 506 induction and rescue therapy in pancreas transplant recipients
    Stratta, RJ
    Taylor, RJ
    Castaldo, P
    Sindhi, R
    Sudan, D
    Weide, LG
    Frisbie, K
    Cushing, KA
    Jerius, J
    Radio, SJ
    TRANSPLANTATION PROCEEDINGS, 1996, 28 (02) : 991 - 992
  • [35] Thymoglobulin Versus Basiliximab Induction Therapy in Low-Risk Kidney Transplant Recipients: A Single-Center Experience
    Lee, H.
    Lee, S.
    Jeon, J. S.
    Kwon, S. H.
    Noh, H.
    Han, D. C.
    Yun, S.
    Song, D.
    TRANSPLANTATION PROCEEDINGS, 2018, 50 (05) : 1285 - 1288
  • [36] Effect of Induction Therapy with Thymoglobulin on Outcome in Hepatitis C Infected Kidney Transplant Recipients: A Single Center Experience.
    Linatoc, J.
    Ren, Q.
    Behnke, M.
    Posner, M.
    King, A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 : 85 - 85
  • [37] Role of Induction Therapy in Low Immune Risk Kidney Transplant Recipients.
    Chopra, B.
    Sureshkumar, K.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2016, 16 : 538 - 538
  • [38] Induction therapy with basiliximab versus thymoglobulin in African-American kidney transplant recipients
    Haririan, A
    Morawski, K
    Sillix, DH
    El-Amm, JM
    Garnick, J
    West, MS
    Granger, DK
    Migdal, SD
    Gruber, SA
    TRANSPLANTATION, 2005, 79 (06) : 716 - 721
  • [39] Incidence and Outcomes of CMV Infection in Pancreas Transplant with Thymoglobulin Induction: A Single Center Experience.
    Abusalah, W.
    Yadav, A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2022, 22 : 859 - 859
  • [40] Early Experience with 4-Drug Maintenance Immunosuppression in Kidney and Pancreas Transplant Recipients.
    Mouawad, S.
    Shoemaker, C.
    Geyston, J.
    Lucar, A. Nishio
    AMERICAN JOURNAL OF TRANSPLANTATION, 2022, 22 : 1094 - 1094
12345